Press Releases
Date Title and Summary View
May 3, 2001 HOLLISTON, Mass., May 3 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will make a presentation at the Dain Rauscher Wessels Genomics & Life Sciences Conference to be held May 7th and 8th in New York City. The theme of the conference will be - Biot...
May 1, 2001 HOLLISTON, Mass., May 1 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the acquisition of Warner Instruments Corporation, a leader in innovative cell and tissue electro-physiology research products. Formed in 1988, Warner Instruments designs, manufactures, and markets a wide array of products for cell...
Apr 25, 2001 HOLLISTON, Mass., April 25 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the first quarter of 2001. Financial highlights for the three months ended March 31, 2001 were as follows: Revenues for the first quarter of 2001 grew 29% before unfavorable foreign exchange effects. Includin...
Apr 19, 2001 HOLLISTON, Mass., April 19 /PRNewswire/ --Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce results for the first quarter of 2001 after the market closes on Wednesday, April 25, 2001. At 2:00 p.m. Eastern Time on April 26, 2001, management will host a conference call to discuss the Company's quarterly results, along with ...
Apr 10, 2001 HOLLISTON, Mass., April 10 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported that the United States District Court, District of Massachusetts has denied Harvard University's request for a preliminary injunction prohibiting Harvard Bioscience, Inc. from using the name "Harvard." The Court did issue an order that directs H...
Mar 28, 2001 HOLLISTON, Mass., March 28 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that David Green, President of Harvard Bioscience, will be a featured speaker at the Thomas Weisel Partners Healthcare Conference 2001 to be held April 2nd and 3rd in San Francisco, California. The theme of the conference will b...
Mar 19, 2001 HOLLISTON, Mass., March 19 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of MitoScan® toxicity screening assays, which offer rapid, convenient alternatives to cellular assays. (Photo: http://www.newscom.com/cgi-bin/prnh/20010319/NEM031) ...
Feb 27, 2001 HOLLISTON, Mass., Feb. 27 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the introduction of ScanTox™, a drug safety evaluation tool that provides a more sensitive means of lead optimization than currently available, as well as an in vitro alternative to the much criticized Drai...
Feb 22, 2001 HOLLISTON, Mass., Feb. 22 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today reported record revenues for the year and the quarter ended December 31, 2000. Revenue for the fourth quarter of 2000 grew 18% before unfavorable foreign exchange effects. Including foreign exchange effects revenue for the fourth quarter ...
Feb 14, 2001 HOLLISTON, Mass., Feb. 14 /PRNewswire/ -- Harvard Bioscience, Inc. (Nasdaq: HBIO) You are invited to listen to our fourth quarter and year ended 2000 conference call. It will be broadcast live over the Internet on Friday, February 23 at 10:00 a.m., EST. Chane Graziano, CEO, David Green, President, and Jim Warren, CFO will conduct the call....
FirstPrevious ...
30
NextLast
= add release to Briefcase